whitepaper Whitepaper: Unique solutions for drug discovery and development 10 November 2022 | By Cell SIgnaling Technology Looking for solutions to resolve your unique challenges? We offer several customized products and services to move your discovery forward.
webinar Translating complex, high-parameter immune data from clinical samples into actionable disease insights 1 November 2022 | By Standard BioTools Watch our on-demand webinar to hear about advances toward precision medicine through the use of cutting-edge methods and analysing critical patient immune data in response to therapies and disease progression.
news Pre-clinical trials show drug inhibits inflammasome in COVID-19 cases 25 October 2022 | By Izzy Wood (Drug Target Review) Anti-inflammatory effects of niclosamide, observed in a new pre-clinical study, were due to inhibition of the inflammasome, a protein complex presented in the interior of defence cells.
whitepaper Application note: Flow cytometry platform 26 September 2022 | By Sartorius iQue® Compendium of iQue® advanced flow cytometry platform application posters: Antibody discovery and immuno-oncology.
whitepaper ebook: Binding kinetics in drug discovery 16 September 2022 | By BMG Labtech GmbH This ebook explores the role of binding kinetics in drug discovery, current methods for kinetic parameter analysis, novel approaches and applications.
news Researchers discover compound that could treat Chagas disease 14 September 2022 | By Victoria Rees (Drug Target Review) Using screening techniques, researchers have identified the compound called AN15368 which works as an antiparasitic against Chagas disease.
whitepaper Case Study: Trust in your results — A flow cytometry case study 13 September 2022 | By Sartorius Trust in your results — Experience the benefits of iQue® advanced flow cytometry.
webinar CHO targeted integration platform for accelerated antibody development 7 September 2022 | By Sartorius Watch this webinar to hear from Dr Yuansheng Yang as he introduces a CHO cell-based technology allowing simultaneous display and secretion of antibodies for accelerating the process of antibody development.
whitepaper Application note: Quantifying T Cell response in 3D tumour spheroids 29 August 2022 | By Sartorius iQue® Application note: Quantifying T Cell response in 3D tumour spheroids using advanced flow cytometry workflows.
whitepaper Publications review: Applications in infectious disease and immuno-oncology 15 August 2022 | By Sartorius iQue® This publications review overviews advanced flow cytometry applications in infectious disease and immuno-oncology.
whitepaper Guide: How to build an effective protein degrader 11 August 2022 | By NanoTemper Technologies This guide highlights the four major stages of TPD, the challenges at each step and questions you should ask yourself.
whitepaper Whitepaper: High throughput, multi-parametric analysis 1 August 2022 | By Sartorius iQue® This whitepaper overviews how high throughput, multi-parametric analysis accelerates antibody discovery workflows.
news Researchers discover new compounds to potentially combat leukaemia 19 July 2022 | By Victoria Rees (Drug Target Review) Researchers from the US have identified several new small molecules that can induce mitophagy in leukaemia cells.
whitepaper Whitepaper: CAR T-Cell analysis with modular antibodies using SpyTag protein ligation 17 June 2022 | By Bio-Rad Laboratories Here Bio-Rad presents the generation of specific anti-CAR T-cell antibodies to show how CAR T-cell analysis benefits from our modular antibody assembly technology using SpyTag-SpyCatcher protein ligation.
webinar Assays for protein degradation therapeutics to accelerate undruggable proteome discoveries 9 May 2022 | By PerkinElmer and C4 Looking for a way to address the undruggable proteins in the human body? Watch this free on-demand webinar where industry experts discuss strategies to accelerate TPD drug discovery efforts using high-throughput cell-based assays.
